Malaysia vs Russia: Life science patents granted, by technology
Malaysia
343 patents
in 2023
Russia
433 patents
in 2022
Malaysia rank
11th
Russia rank
10th
Life science patents granted, by technology over time
- Malaysia
- Russia
How they compare
Russia currently reports 433 patents against 343 patents in Malaysia, a difference of 90 patents.
That makes Russia's figure about 1.3 times Malaysia's.
The two have swapped places 1 time across 31 shared years of data; in 1992 it was Russia ahead.
Malaysia ranks 11th and Russia ranks 10th of 65 countries.
Russia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Malaysia | Russia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 77.88 patents | 842.38 patents | 764.5 patents | Russia |
| 2000s | 161.2 patents | 1,208 patents | 1,046 patents | Russia |
| 2010s | 199.8 patents | 1,511 patents | 1,312 patents | Russia |
| 2020s | 263.67 patents | 1,056 patents | 792.67 patents | Russia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by technology, Malaysia or Russia?
- Russia, at 433 patents against 343 patents in Malaysia as of 2022.
- What is the difference in life science patents granted, by technology between Malaysia and Russia?
- 90 patents, with Russia ahead.
- How many years of comparable data are there for Malaysia and Russia?
- 31 years are reported by both, from 1992 to 2022.
- How do Malaysia and Russia rank globally for life science patents granted, by technology?
- Malaysia ranks 11th and Russia ranks 10th of 65 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) β processed by Our World in Data, published as Life science patents granted, by technology. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of pharmaceutical patents granted by the filing office in a given year. Pharmaceutical patents typically cover new drugs, biological treatments or vaccines.